Stockhub

Mithra Pharmaceuticals SA: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 August 2022

  • curprev 22:2822:28, 21 August 2022 >Nick 1,076 bytes +1,076 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also devel..."
Retrieved from "https://stockhub.co/research/Mithra_Pharmaceuticals_SA"